Shared and unique aspects of ligand‐ and voltage‐gated ion‐channel gating

Ligandand voltage-gated ion channels form a large superfamily of membranebound signalling proteins that fulfil many important roles in health and disease (Hille, 2001). Voltage-gated ion channels are primarily responsible for the generation and propagation of action potentials in excitable tissue (Stuart et al. 1997; Catterall et al. 2005; Jan & Jan, 2012) whereas ligand-gated ion channels constitute the hardwiring of chemical synapses – though they also fine tune synaptic strength during periods of sustained patterned activity and altered homeostasis (Turrigiano, 2008; Nicoll, 2017). Together, the combined activity of ligandand voltage-gated ion channels gives rise to many complex physiological processes from cardiac and skeletal muscle contraction to the more enigmatic behaviours of the CNS such as cognition and memory. The study of ion channels has undergone unprecedented advances in recent years with the convergence of several scientific disciplines on this important research topic. Structural biology has emerged as a leading approach to understand ion channel function as well as drug action (Gouaux & Mackinnon, 2005). Furthermore, recent advances in genetic manipulations, particularly in rodents, have permitted ion channel families to be assigned distinct roles in health and disease. To explore this emerging area of physiology, The Journal of Physiology sponsored a symposium at the 2017 International Union of Physiological Sciences meeting in Rio de Janeiro, Brazil entitled ‘Shared and unique aspects of the gating mechanisms of ligandand voltagegated ion-channels’. Chaired by Journal editors Drs Yoshihiro Kubo and Derek Bowie, it brought together five researchers (see Fig. 1) whose work is at the forefront of this rapidly developing field of study. This issue of The Journal of Physiology brings together three timely review articles and an original paper that capture some of the ideas, discussions and debates that arose during the symposium. Dr Yoshihiro Kubo from Japan’s National Institute for Physiological Sciences opened the symposium by presenting recent data from his lab where they looked at the unexpected effect of the broad-spectrum antiparasitic agent ivermectin on the Gprotein-gated inwardly rectifying K+ (or GIRK) channel (Chen et al. 2017). Since its discovery in soil samples of bacteria taken near a Japanese golf course in the 1970s (Laing et al. 2017), ivermectin has proven to be one of the most effective drugs used by veterinarians and health professionals to combat parasite infection. Although its anthelmintic action is primarily mediated by targeting the activity of nematode glutamate-gated chloride channels to curtail motility, feeding and reproductive behaviour (Yates et al. 2003), ivermectin has also been shown to affect other ion channel families such as GABAA, glycine and nicotinic acetylcholine receptors (Wolstenholme & Rogers, 2005). This multifaceted nature of ivermectin pharmacology is the main topic of the comprehensive review by Chen and Kubo where they explore shared and unique modulatory properties of ivermectin on a variety of ligand-gated ion channels (Chen & Kubo, 2018). Insight into ivermectin’s action on each ion channel target is beautifully illustrated by the authors’ effective use of X-ray crystallographic data to compare and contrast the structural determinants of each binding pocket. Given its hydrophobicity, ivermectin binds to residues lining the transmembrane (TM) regions of Cys-loop ligand-gated ion channels, such as the nematode glutamategated chloride channels and mammalian glycine receptors. The binding of ivermectin near the extracellular surface of the plasma membrane is critical as it induces the rotation of TM regions to facilitate channel opening. Surprisingly, however, ivermectin binds to GIRK channels on a different site, which lies at the interface of the TM region and intracellular domains (Chen et al. 2017). The authors conclude that although ivermectin binds to many ion channel targets, its clinical value as a drug with few side effects is afforded by its preferred high-affinity binding to nematode glutamate-gated chloride channels. Dr Cecilia Bouzat from the National University of the South (UNS), Bahı̀a Blanca, Argentina, presented recent work from her lab on the functional and pharmacological properties of α7 subunitcontaining nicotinic acetylcholine receptors (nAChRs) (daCosta et al. 2011; Andersen et al. 2013, 2016; Nielsen et al. 2018). Although nAChRs are expressed throughout the body, α7 receptors are especially concentrated in the mammalian brain where they exhibit both ionotropic and metabotropic functions (Wu et al. 2016; Kabbani & Nichols, 2018). They are also implicated in several CNS disorders (Dineley et al. 2015) and consequently there has been a need to develop selective drugs. The review article by Bouzat and colleagues (Bouzat et al. 2018) highlights these recent advances in our understanding of the α7 nAChR. Potentiation of the α7 receptor has been identified as a novel therapeutic strategy to treat several neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases, and inflammatory disorders, whereas drugs which reduce receptor activity may be beneficial in the treatment of cancer cell proliferation (Bouzat et al. 2018). Dr Frank Bosmans from Johns Hopkins University in Baltimore, MD, USA talked about the pioneering work that he and his colleagues have performed using animal toxins to probe the functional behaviour of voltage-gated ion channels, particularly voltage-gated Na+ channels (Nav) (Bosmans & Swartz, 2010; Kalia et al. 2015). Voltage-gated Nav channels are primarily responsible for the rapid upstroke of the action potential in cardiac and skeletal muscle as well as being integral to the complex firing properties of central neurons. Not surprisingly, therefore, Nav channels are involved in many physiological processes and have also been implicated in numerous pathologies including cardiac dysfunction, neuropathic pain and genetic forms of epilepsy, such as Dravet syndrome (Abriel, 2010; Catterall, 2012; Waxman, 2013; Chen-Izu et al. 2015). Given all of this, the Nav channel community has been developing a comprehensive understanding of how the structural architecture